Which region held the largest market share in the Acute Respiratory Distress Syndrome Treatment Market market?

North America is the region to held the largest market share with 39% growth. Read More

Who are the key players in the Acute Respiratory Distress Syndrome Treatment Market market?

Air Liquide SA, Athersys Inc., Boston Scientific Corporation, Dragerwerk AG and Co. KGaA, Getinge AB, Koninklijke Philips N.V., LivaNova PLC, Medtronic, Nihon Kohden Corp., .... Read More

Which Segment has the largest market share in the Acute Respiratory Distress Syndrome Treatment Market market?

Distribution Channel is the segment that has the largest market share in the market. Read More

Acute Respiratory Distress Syndrome Treatment Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, France, China - Size and Forecast 2024-2028

Q: How much is the Acute Respiratory Distress Syndrome Treatment Market market?

The acute respiratory distress syndrome treatment market market size is estimated to grow at $$ 1.22 bn in 2023. Read More

Q: What is the growth rate of the Acute Respiratory Distress Syndrome Treatment Market market?

The growth rate of the acute respiratory distress syndrome treatment market year-over-year is 6.9%. Read More

Published: Mar 2024
Pages: 161
SKU: IRTNTR77729

Enjoy complimentary customisation on priority with our Enterprise License!

Acute Respiratory Distress Syndrome Treatment Market Size 2024-2028

The acute respiratory distress syndrome treatment market size is forecast to increase by USD 1.22 billion at a CAGR of 6.9% between 2023 and 2028. The acute respiratory distress syndrome (ARDS) treatment market is witnessing significant growth due to several key trends. The growing focus on lung-protective ventilation strategies is a major factor driving market growth. These strategies aim to minimize ventilator-induced lung injury and improve patient outcomes. Additionally, there is a growing interest in immunomodulatory therapies for ARDS, which have shown promise in reducing inflammation and improving survival rates. However, the heterogeneity of the patient population poses a significant challenge to the market. ARDS can result from various underlying conditions, making it difficult to develop a one-size-fits-all treatment approach. Despite these challenges, advancements in technology and research are expected to provide new opportunities for market growth.

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global acute respiratory distress syndrome treatment market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global acute respiratory distress syndrome treatment market 2018 - 2022 ($ billion)

4.2 Distribution Channel Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ billion)

4.3 Route of Administration Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Route of Administration Segment 2018 - 2022 ($ billion)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

6.1 Market segments
- Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)

6.2 Comparison by Distribution Channel
- Exhibit 32: Chart on Comparison by Distribution Channel
- Exhibit 33: Data Table on Comparison by Distribution Channel

6.3 Hospitals pharmacies - Market size and forecast 2023-2028
- Exhibit 34: Chart on Hospitals pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Hospitals pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Hospitals pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Hospitals pharmacies - Year-over-year growth 2023-2028 (%)

6.4 Retail pharmacies - Market size and forecast 2023-2028
- Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)

6.5 Online pharmacies - Market size and forecast 2023-2028
- Exhibit 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)

6.6 Market opportunity by Distribution Channel
- Exhibit 46: Market opportunity by Distribution Channel ($ billion)
- Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Route of Administration

7.1 Market segments
- Exhibit 48: Chart on Route of Administration - Market share 2023-2028 (%)
- Exhibit 49: Data Table on Route of Administration - Market share 2023-2028 (%)

7.2 Comparison by Route of Administration
- Exhibit 50: Chart on Comparison by Route of Administration
- Exhibit 51: Data Table on Comparison by Route of Administration

7.3 Oral - Market size and forecast 2023-2028
- Exhibit 52: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
- Exhibit 53: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
- Exhibit 54: Chart on Oral - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Oral - Year-over-year growth 2023-2028 (%)

7.4 Injection - Market size and forecast 2023-2028
- Exhibit 56: Chart on Injection - Market size and forecast 2023-2028 ($ billion)
- Exhibit 57: Data Table on Injection - Market size and forecast 2023-2028 ($ billion)
- Exhibit 58: Chart on Injection - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Injection - Year-over-year growth 2023-2028 (%)

7.5 Inhalation - Market size and forecast 2023-2028
- Exhibit 60: Chart on Inhalation - Market size and forecast 2023-2028 ($ billion)
- Exhibit 61: Data Table on Inhalation - Market size and forecast 2023-2028 ($ billion)
- Exhibit 62: Chart on Inhalation - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Inhalation - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by Route of Administration
- Exhibit 64: Market opportunity by Route of Administration ($ billion)
- Exhibit 65: Data Table on Market opportunity by Route of Administration ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 67: Chart on Market share by geography 2023-2028 (%)
- Exhibit 68: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 69: Chart on Geographic comparison
- Exhibit 70: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 China - Market size and forecast 2023-2028
- Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)

9.9 Germany - Market size and forecast 2023-2028
- Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.10 UK - Market size and forecast 2023-2028
- Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.11 France - Market size and forecast 2023-2028
- Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ billion)
- Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ billion)
- Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 107: Market opportunity by geography ($ billion)
- Exhibit 108: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 109: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 110: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 111: Overview on factors of disruption

11.4 Industry risks
- Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 113: Vendors covered

12.2 Market positioning of vendors
- Exhibit 114: Matrix on vendor position and classification

12.3 APEPTICO Forschung und Entwicklung GmbH
- Exhibit 115: APEPTICO Forschung und Entwicklung GmbH - Overview
- Exhibit 116: APEPTICO Forschung und Entwicklung GmbH - Product / Service
- Exhibit 117: APEPTICO Forschung und Entwicklung GmbH - Key offerings

12.4 Athersys Inc.
- Exhibit 118: Athersys Inc. - Overview
- Exhibit 119: Athersys Inc. - Product / Service
- Exhibit 120: Athersys Inc. - Key offerings

12.5 Dragerwerk AG and Co. KGaA
- Exhibit 121: Dragerwerk AG and Co. KGaA - Overview
- Exhibit 122: Dragerwerk AG and Co. KGaA - Business segments
- Exhibit 123: Dragerwerk AG and Co. KGaA - Key offerings
- Exhibit 124: Dragerwerk AG and Co. KGaA - Segment focus

12.6 Edesa Biotech Inc.
- Exhibit 125: Edesa Biotech Inc. - Overview
- Exhibit 126: Edesa Biotech Inc. - Product / Service
- Exhibit 127: Edesa Biotech Inc. - Key offerings

12.7 Fisher and Paykel Healthcare Corp. Ltd.
- Exhibit 128: Fisher and Paykel Healthcare Corp. Ltd. - Overview
- Exhibit 129: Fisher and Paykel Healthcare Corp. Ltd. - Product / Service
- Exhibit 130: Fisher and Paykel Healthcare Corp. Ltd. - Key news
- Exhibit 131: Fisher and Paykel Healthcare Corp. Ltd. - Key offerings

12.8 GE Healthcare Technologies Inc.
- Exhibit 132: GE Healthcare Technologies Inc. - Overview
- Exhibit 133: GE Healthcare Technologies Inc. - Business segments
- Exhibit 134: GE Healthcare Technologies Inc. - Key news
- Exhibit 135: GE Healthcare Technologies Inc. - Key offerings
- Exhibit 136: GE Healthcare Technologies Inc. - Segment focus

12.9 Getinge AB
- Exhibit 137: Getinge AB - Overview
- Exhibit 138: Getinge AB - Business segments
- Exhibit 139: Getinge AB - Key news
- Exhibit 140: Getinge AB - Key offerings
- Exhibit 141: Getinge AB - Segment focus

12.10 Hamilton Medical AG
- Exhibit 142: Hamilton Medical AG - Overview
- Exhibit 143: Hamilton Medical AG - Product / Service
- Exhibit 144: Hamilton Medical AG - Key offerings

12.11 Koninklijke Philips N.V.
- Exhibit 145: Koninklijke Philips N.V. - Overview
- Exhibit 146: Koninklijke Philips N.V. - Business segments
- Exhibit 147: Koninklijke Philips N.V. - Key news
- Exhibit 148: Koninklijke Philips N.V. - Key offerings
- Exhibit 149: Koninklijke Philips N.V. - Segment focus

12.12 LivaNova PLC
- Exhibit 150: LivaNova PLC - Overview
- Exhibit 151: LivaNova PLC - Business segments
- Exhibit 152: LivaNova PLC - Key news
- Exhibit 153: LivaNova PLC - Key offerings
- Exhibit 154: LivaNova PLC - Segment focus

12.13 Medtronic
- Exhibit 155: Medtronic - Overview
- Exhibit 156: Medtronic - Business segments
- Exhibit 157: Medtronic - Key news
- Exhibit 158: Medtronic - Key offerings
- Exhibit 159: Medtronic - Segment focus

12.14 Nihon Kohden Corp.
- Exhibit 160: Nihon Kohden Corp. - Overview
- Exhibit 161: Nihon Kohden Corp. - Product / Service
- Exhibit 162: Nihon Kohden Corp. - Key offerings

12.15 ResMed Inc.
- Exhibit 163: ResMed Inc. - Overview
- Exhibit 164: ResMed Inc. - Business segments
- Exhibit 165: ResMed Inc. - Key news
- Exhibit 166: ResMed Inc. - Key offerings
- Exhibit 167: ResMed Inc. - Segment focus

12.16 Smiths Group Plc
- Exhibit 168: Smiths Group Plc - Overview
- Exhibit 169: Smiths Group Plc - Business segments
- Exhibit 170: Smiths Group Plc - Key news
- Exhibit 171: Smiths Group Plc - Key offerings
- Exhibit 172: Smiths Group Plc - Segment focus

12.17 Vyaire Medical Inc.
- Exhibit 173: Vyaire Medical Inc. - Overview
- Exhibit 174: Vyaire Medical Inc. - Product / Service
- Exhibit 175: Vyaire Medical Inc. - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 176: Inclusions checklist
- Exhibit 177: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 178: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 179: Research methodology
- Exhibit 180: Validation techniques employed for market sizing
- Exhibit 181: Information sources